Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer

Sci Rep. 2024 Mar 13;14(1):6087. doi: 10.1038/s41598-024-55384-z.
No abstract available

Publication types

  • Published Erratum